Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Peters

Showing results (31-40 of 259) with videos related to

Pageof 26
Sort By:
Biomolecules|May 24, 2024
The Cerebrospinal Fluid Free-Glycans Hex<sub>1</sub> and HexNAc<sub>1</sub>Hex<sub>1</sub>Neu5Ac<sub>1</sub> as Potential Biomarkers of Alzheimer's DiseaseLynn Krüger, Karina Biskup, Carola G Schipke, et al.
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease ContinuumFelix Menne, Carola Gertrud Schipke, Arne Klostermann, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|March 5, 2016
[Acceptance of dementia diagnostics by getriatric hospital patients : Comparison of various investigation methods with emphasis on FDG-PET imaging]Melanie Estrella, Anna Roberts, Anja Mäurer, et al.
Metabolites|June 21, 2020
Pursuing Experimental Reproducibility: An Efficient Protocol for the Preparation of Cerebrospinal Fluid Samples for NMR-based Metabolomics and Analysis of Sample DegradationBenjamin Albrecht, Elena Voronina, Carola Schipke, et al.
Psychiatry Research. Neuroimaging|December 28, 2016
Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluidCarola G Schipke, Norman Koglin, Santiago Bullich, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia SubjectsPiotr Lewczuk, Johannes Kornhuber, , et al.
Journal of Alzheimer'S Disease : JAD|July 9, 2009
Astrocyte function is modified by Alzheimer's disease-like pathology in aged miceOliver Peters, Carola G Schipke, Andreas Philipps, et al.
Nature Communications|May 5, 2025
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trialJanine Kutzsche, Nicoleta Carmen Cosma, Gunther Kauselmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2020
Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signalingAntonino Asaro, Anne-Sophie Carlo-Spiewok, Anna R Malik, et al.
Plos One|July 17, 2018
Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's diseaseKatja Derkow, Rosa Rössling, Carola Schipke, et al.
Pageof 26

Showing results (31-40 of 259) with videos related to

Sort By:
Pageof 26
Biomolecules|May 24, 2024
The Cerebrospinal Fluid Free-Glycans Hex<sub>1</sub> and HexNAc<sub>1</sub>Hex<sub>1</sub>Neu5Ac<sub>1</sub> as Potential Biomarkers of Alzheimer's DiseaseLynn Krüger, Karina Biskup, Carola G Schipke, et al.
Journal of Alzheimer'S Disease : JAD|October 19, 2020
Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease ContinuumFelix Menne, Carola Gertrud Schipke, Arne Klostermann, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|March 5, 2016
[Acceptance of dementia diagnostics by getriatric hospital patients : Comparison of various investigation methods with emphasis on FDG-PET imaging]Melanie Estrella, Anna Roberts, Anja Mäurer, et al.
Metabolites|June 21, 2020
Pursuing Experimental Reproducibility: An Efficient Protocol for the Preparation of Cerebrospinal Fluid Samples for NMR-based Metabolomics and Analysis of Sample DegradationBenjamin Albrecht, Elena Voronina, Carola Schipke, et al.
Psychiatry Research. Neuroimaging|December 28, 2016
Correlation of florbetaben PET imaging and the amyloid peptide Aß42 in cerebrospinal fluidCarola G Schipke, Norman Koglin, Santiago Bullich, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia SubjectsPiotr Lewczuk, Johannes Kornhuber, , et al.
Journal of Alzheimer'S Disease : JAD|July 9, 2009
Astrocyte function is modified by Alzheimer's disease-like pathology in aged miceOliver Peters, Carola G Schipke, Andreas Philipps, et al.
Nature Communications|May 5, 2025
Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trialJanine Kutzsche, Nicoleta Carmen Cosma, Gunther Kauselmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2020
Apolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signalingAntonino Asaro, Anne-Sophie Carlo-Spiewok, Anna R Malik, et al.
Plos One|July 17, 2018
Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's diseaseKatja Derkow, Rosa Rössling, Carola Schipke, et al.
Pageof 26